Dr. Grimm’s major interests are clinical trials for renal, bladder, and prostate cancers, and translational research with a focus on biomarkers in renal cell and non–muscle-invasive bladder cancers.

Dr. Grimm is chairing the German Guidelines Groups for Prostate Cancer and a member of the Bladder Cancer Group. He currently serves on the board of the German Society of Urology and the EAU Section of Oncological Urology. He is also a member of the Scientific Congress Office of the European Association of Urology. Dr. Grimm has authored numerous oncology publications in peer-reviewed journals and continues to lead as an investigator in phase 2 and 3 uro-oncology trials.